When was PPD founded?

PPD was founded in 1985 and raised its 1st funding round 20 years after it was founded.

Where is PPD located?

PPD is headquartered in Wilmington, United States. It is registered at Wilmington, North Carolina.

How many employees does PPD have?

As of Mar 31, 2026, the latest employee count at PPD is 20982.

Is PPD a funded company?

PPD is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jul 01, 2005.

When was the latest funding round of PPD?

PPD's latest funding was a $***** Grant (prize money) round on Oct 13, 2023, with participation from 1 investor.

What is the annual revenue of PPD?

Annual revenue of PPD is $4.68B as on Dec 31, 2020.

Where does PPD rank among its competitors?

PPD ranks 1st amongst 522 active competitors, of which 3 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Medicus Pharma, which secured $11M in May, 2024.

Who are the top competitors of PPD?

PPD's top competitors include Kayentis, Cambrian BioPharma and H.U. Group Holdings. Among them, Medicus Pharma secured the most recent funding round in May, 2024.

PPD - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Website: ppd.com
Social
Phone Number: +1 **********
Registered Address: Wilmington, North Carolina

Key Metrics

Founded Year

1985

Location

Wilmington, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), Oct 13, 2023, $*****

Investors

HHS

Ranked

1^st among 522 active competitors

Annual Revenue

$4.68B as on Dec 31, 2020

Employee Count

20,982 as on Mar 31, 2026

Investment & Acquisitions

Medable & 13 more

Similar Companies

Kayentis & 523 more

Exit Details

Acquired by Thermo Fisher Scientific (Apr 15, 2021)

View PPD's full profile

PPD is associated with 4 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PPD, INC. CIN: 1793294 , United States, Active	Apr 12, 2017	$4.68B (As on Dec 31, 2020)	-	-
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC CIN: 561640186 , United States, Active	Dec 26, 999	-	14922 (As on Dec 31, 2023)	-
PPD TRADE s.r.o. CIN: 03629805 , Czech Republic, Active	Dec 09, 2014	-	-
PPD PHARMACEUTICAL DEVELOPMENT INDIA PRIVATE LIMITED CIN: U73100MH2004PTC144454 , India, Active	Feb 10, 2004	$54.1M (As on Mar 31, 2025)	-

PPD got acquired by Thermo Fisher Scientific on Apr 15, 2021 at an acquisition amount of $*****.

Click here to take a look at PPD's acquisition in detail

PPD has raised funding over 6 rounds. Its first funding round was on Jul 01, 2005. Its latest funding round was a Grant (prize money) round on Oct 13, 2023 for $*****. 1 investor participated in its latest round. PPD has 1 institutional investor.

Here is the list of recent funding rounds of PPD:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 13, 2023	8364605	Grant (prize money)	5664601	9483657	3571876	9760672
May 20, 2019	5522609	Conventional Debt	7458478	8820134	5601628	4086438
Dec 2011	5657037	PE	5528658	8145099	9545184	The Carlyle Group

Access funding benchmarks and valuations. Sign up today!

View details of PPD's funding rounds and investors

The founders of PPD is Fred Eshelman.

Here are the details of PPD's key team members:

Fred Eshelman: Founder of PPD.
David Simmons: CEO of PPD.
Contact Info: 1 email address

View details of PPD's Founder profiles and Board Members

PPD's employee count trend

PPD has 20,982 employees as of Mar 26. Here is PPD's employee count trend over the years:

Uncover PPD's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PPD include Kayentis, Cambrian BioPharma and H.U. Group Holdings. Here is the list of Top 10 competitors of PPD, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	PPD 1985, Wilmington (United States), Acquired	CRO providing diversified clinical development services	-	HHS	63/100
2nd	Kayentis 2003, Meylan (France), Series D	Provider of electronic clinical outcome assessment solutions for clinical trials	$36.2M	Extens, XAnge & 5 others	48/100
3rd	Cambrian BioPharma 2019, Brooklyn (United States), Series C	Developer of medicines and therapies	$211M	Anthos Capital, Apeiron Investment Group ... & 20 others	48/100
4th	H.U. Group Holdings 1950, Shinjuku (Japan), Public	Provider of clinical testing, diagnostics, and healthcare services. This entity offers a range of services encompassing laboratory testing and related services, in-vitro diagnostics, healthcare-related services, and research and development. Their activities include supporting research in clinical laboratory medicine, fostering technological advancements, and contributing to the overall progress of medical science and healthcare technology. They also engage in intellectual property activities and have initiatives addressing public health concerns.	-	-	42/100
5th	Symphony Health 2012, Horsham (United States), Acquired	Provider of clinical research, consulting, and commercial services for healthcare sectors	-	Autonomy Ventures, STG	42/100
6th	Medicus Pharma 2008, Toronto (Canada), Public	Clinical stage, multi-strategy holding company focused on investing in and accelerating novel therapies in the biotechnology and life sciences industry	-	-	40/100
7th	Volv Global 2017, Epalinges (Switzerland), Funding Raised	Provider of AI and machine learning solutions for healthcare insights	-	Seedlink	37/100
8th	Peachtree BioResearch Solutions 2008, Marietta (United States), Unfunded	Provider of clinical research services for biotechnology, pharmaceutical, and medical device companies	-	-	36/100
9th	Hangzhou Baicheng Pharmaceutical Technology 2011, Hangzhou (China), Public	Provider of comprehensive pharmaceutical research and development services across drug lifecycles	-	Paradise Silicon Valley Asset Management Group	35/100
10th	YD Biopharma 2004, Taipei (Taiwan), Unfunded	Provider of diagnostic and therapeutic technologies, focusing on exosome science and cancer detection	-	-	34/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on PPD's competitors? Click here to see the top ones

PPD has made 5 investments in companies including Medable and Medable. PPD has also acquired 9 companies including Evidera and Synexus.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 05, 2021	Investments	Medable	2012	Palo Alto (United States)
Oct 29, 2020	Investments	Medable	2012	Palo Alto (United States)
Aug 20, 2020	Investments	Science 37	2014	Los Angeles (United States)